Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

Cardiovasc Diabetol · 2012 · PMC3502168 · PMID 23150952

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

close to significancep=0.066so close (0.05 < p ≤ 0.1)

Kaplan-Meier analysis of total mortality during one year was close to significance in favor of the combination (p=0.066).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.